Kidney Diseases Completed Phase 4 Trials for Regadenoson (DB06213)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00863707A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentDiagnostic